(Article Reason 2 O O
by Reason 2 O O
David Reason 2 O O
Bell Reason 2 O O
republished Reason 2 O O
from Reason 2 O O
[Brownstone.org](https://brownstone.org/articles/the-false-messaging-on-vaccines-given-to-pregnant-women/)) Reason 2 O O
By Reason 2 O O
late Reason 2 O O
2021, Reason 2 O O
working-age Reason 2 O O
women, Reason 2 O O
including Reason 2 O O
those Reason 2 O O
who Reason 2 O O
were Reason 2 O O
pregnant, Reason 2 O O
were Reason 2 O O
being Reason 2 O O
thrown Reason 2 O O
out Reason 2 O O
of Reason 2 O O
employment Reason 2 O O
for Reason 2 O O
not Reason 2 O O
agreeing Reason 2 O O
to Reason 2 O O
be Reason 2 O O
injected. Reason 2 O O
Those Reason 2 O O
who Reason 2 O O
took Reason 2 O O
the Reason 2 O O
mRNA Reason 2 O O
vaccines Reason 2 O O
did Reason 2 O O
so Reason 2 O O
based Reason 2 O O
on Reason 2 O O
trust Reason 2 O O
in Reason 2 O O
health Reason 2 O O
authorities Reason 2 O O
- Reason 2 O O
the Reason 2 O O
assumption Reason 2 O O
being Reason 2 O O
that Reason 2 O O
they Reason 2 O O
would Reason 2 O O
not Reason 2 O O
have Reason 2 O O
been Reason 2 O O
approved Reason 2 O O
if Reason 2 O O
the Reason 2 O O
evidence Reason 2 O O
was Reason 2 O O
not Reason 2 O O
absolutely Reason 2 O O
clear. Reason 2 O O
The Reason 2 O O
role Reason 2 O O
of Reason 2 O O
regulatory Reason 2 O O
agencies Reason 2 O O
was Reason 2 O O
to Reason 2 O O
protect Reason 2 O O
the Reason 2 O O
public Reason 2 O O
and, Reason 2 O O
therefore, Reason 2 O O
if Reason 2 O O
they Reason 2 O O
were Reason 2 O O
approved, Reason 2 O O
the Reason 2 O O
"vaccines" Reason 2 O O
were Reason 2 O O
safe. Reason 2 O O
Recently, Reason 2 O O
a Reason 2 O O
lengthy Reason 2 O O
vaccine Reason 2 O O
evaluation Reason 2 O O
report Reason 2 O O
sponsored Reason 2 O O
by Reason 2 O O
Pfizer Reason 2 O O
and Reason 2 O O
submitted Reason 2 O O
to Reason 2 O O
the Reason 2 O O
Australian Reason 2 O O
regulator, Reason 2 O O
the Reason 2 O O
Therapeutic Reason 2 O O
Goods Reason 2 O O
Administration Reason 2 O O
(TGA) Reason 2 O O
dated Reason 2 O O
January Reason 2 O O
2021 Reason 2 O O
was Reason 2 O O
[released](https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf) Reason 2 O O
under Reason 2 O O
a Reason 2 O O
Freedom Reason 2 O O
of Reason 2 O O
Information Reason 2 O O
request. Reason 2 O O
The Reason 2 O O
report Reason 2 O O
contains Reason 2 O O
significant Reason 2 O O
new Reason 2 O O
information Reason 2 O O
that Reason 2 O O
had Reason 2 O O
been Reason 2 O O
suppressed Reason 2 O O
by Reason 2 O O
the Reason 2 O O
TGA Reason 2 O O
and Reason 2 O O
by Reason 2 O O
Pfizer Reason 2 O O
itself. Reason 2 O O
Much Reason 2 O O
of Reason 2 O O
this Reason 2 O O
relates Reason 2 O O
directly Reason 2 O O
to Reason 2 O O
the Reason 2 O O
issue Reason 2 O O
of Reason 2 O O
safety Reason 2 O O
in Reason 2 O O
pregnancy, Reason 2 O O
and Reason 2 O O
impacts Reason 2 O O
on Reason 2 O O
the Reason 2 O O
fertility Reason 2 O O
of Reason 2 O O
women Reason 2 O O
of Reason 2 O O
child-bearing Reason 2 O O
age. Reason 2 O O
The Reason 2 O O
whole Reason 2 O O
report Reason 2 O O
is Reason 2 O O
important, Reason 2 O O
but Reason 2 O O
four Reason 2 O O
key Reason 2 O O
data Reason 2 O O
points Reason 2 O O
stand Reason 2 O O
out; Reason 2 O O
We Reason 2 O O
focus Reason 2 O O
on Reason 2 O O
the Reason 2 O O
last Reason 2 O O
three Reason 2 O O
items Reason 2 O O
as, Reason 2 O O
for Reason 2 O O
the Reason 2 O O
first Reason 2 O O
point, Reason 2 O O
it Reason 2 O O
is Reason 2 O O
enough Reason 2 O O
to Reason 2 O O
quote Reason 2 O O
the Reason 2 O O
report Reason 2 O O
itself Reason 2 O O
"Antibodies Reason 2 O O
and Reason 2 O O
T Reason 2 O O
cells Reason 2 O O
in Reason 2 O O
monkeys Reason 2 O O
declined Reason 2 O O
quickly Reason 2 O O
over Reason 2 O O
5 Reason 2 O O
weeks Reason 2 O O
after Reason 2 O O
the Reason 2 O O
second Reason 2 O O
dose Reason 2 O O
of Reason 2 O O
BNT162b2 Reason 2 O O
(V9), Reason 2 O O
raising Reason 2 O O
concerns Reason 2 O O
over Reason 2 O O
long Reason 2 O O
term Reason 2 O O
immunity...". Reason 2 O O
This Reason 2 O O
point Reason 2 O O
indicates Reason 2 O O
that Reason 2 O O
the Reason 2 O O
regulators Reason 2 O O
should Reason 2 O O
have Reason 2 O O
anticipated Reason 2 O O
the Reason 2 O O
rapid Reason 2 O O
decline Reason 2 O O
in Reason 2 O O
efficacy Reason 2 O O
and Reason 2 O O
must Reason 2 O O
have Reason 2 O O
known Reason 2 O O
at Reason 2 O O
the Reason 2 O O
outset Reason 2 O O
that Reason 2 O O
the Reason 2 O O
initial Reason 2 O O
two-dose Reason 2 O O
"course" Reason 2 O O
was Reason 2 O O
unlikely Reason 2 O O
to Reason 2 O O
confer Reason 2 O O
lasting Reason 2 O O
immunity Reason 2 O O
and Reason 2 O O
would, Reason 2 O O
therefore, Reason 2 O O
require Reason 2 O O
multiple Reason 2 O O
repeat Reason 2 O O
doses. Reason 2 O O
This Reason 2 O O
expectation Reason 2 O O
of Reason 2 O O
failure Reason 2 O O
was Reason 2 O O
recently Reason 2 O O
highlighted Reason 2 O O
by Reason 2 O O
Dr Reason 2 O O
Anthony Reason 2 O O
Fauci, Reason 2 O O
former Reason 2 O O
director Reason 2 O O
at Reason 2 O O
the Reason 2 O O
US Reason 2 O O
NIH. Reason 2 O O
The Reason 2 O O
three Reason 2 O O
remaining Reason 2 O O
items Reason 2 O O
should Reason 2 O O
be Reason 2 O O
a Reason 2 O O
major Reason 2 O O
cause Reason 2 O O
for Reason 2 O O
alarm Reason 2 O O
with Reason 2 O O
the Reason 2 O O
pharmaceutical Reason 2 O O
regulatory Reason 2 O O
system. Reason 2 O O
The Reason 2 O O
first, Reason 2 O O
as Reason 2 O O
[revealed](https://pandemictimeline.com/wp-content/uploads/2021/07/Pfizer-report_Japanese-government.pdf) Reason 2 O O
in Reason 2 O O
2021, Reason 2 O O
involved Reason 2 O O
biodistribution Reason 2 O O
studies Reason 2 O O
of Reason 2 O O
the Reason 2 O O
lipid Reason 2 O O
nanoparticle Reason 2 O O
carrier Reason 2 O O
in Reason 2 O O
rats, Reason 2 O O
using Reason 2 O O
a Reason 2 O O
luciferase Reason 2 O O
enzyme Reason 2 O O
to Reason 2 O O
substitute Reason 2 O O
for Reason 2 O O
the Reason 2 O O
mRNA Reason 2 O O
vaccine. Reason 2 O O
The Reason 2 O O
study Reason 2 O O
demonstrated Reason 2 O O
that Reason 2 O O
the Reason 2 O O
vaccine Reason 2 O O
will Reason 2 O O
travel Reason 2 O O
throughout Reason 2 O O
the Reason 2 O O
body Reason 2 O O
after Reason 2 O O
injection, Reason 2 O O
and Reason 2 O O
is Reason 2 O O
found Reason 2 O O
not Reason 2 O O
only Reason 2 O O
at Reason 2 O O
the Reason 2 O O
injection Reason 2 O O
site, Reason 2 O O
but Reason 2 O O
in Reason 2 O O
all Reason 2 O O
organs Reason 2 O O
tested, Reason 2 O O
with Reason 2 O O
high Reason 2 O O
concentration Reason 2 O O
in Reason 2 O O
the Reason 2 O O
ovaries, Reason 2 O O
liver, Reason 2 O O
adrenal Reason 2 O O
glands, Reason 2 O O
and Reason 2 O O
spleen. Reason 2 O O
Authorities Reason 2 O O
who Reason 2 O O
assured Reason 2 O O
vaccinated Reason 2 O O
people Reason 2 O O
in Reason 2 O O
early Reason 2 O O
2021 Reason 2 O O
that Reason 2 O O
the Reason 2 O O
vaccine Reason 2 O O
stays Reason 2 O O
in Reason 2 O O
the Reason 2 O O
arm Reason 2 O O
were, Reason 2 O O
as Reason 2 O O
we Reason 2 O O
have Reason 2 O O
known Reason 2 O O
for Reason 2 O O
two Reason 2 O O
years, Reason 2 O O
lying. Reason 2 O O
Lipid Reason 2 O O
concentration Reason 2 O O
per Reason 2 O O
gram, Reason 2 O O
recalculated Reason 2 O O
as Reason 2 O O
percentage Reason 2 O O
of Reason 2 O O
injection Reason 2 O O
site. Reason 2 O O
ORGAN Reason 2 O O
48 Reason 2 O O
HOURS Reason 2 O O
Âµg Reason 2 O O
lipid Reason 2 O O
equiv/g Reason 2 O O
TOTAL Reason 2 O O
CONC Reason 2 O O
In Reason 2 O O
terms Reason 2 O O
of Reason 2 O O
the Reason 2 O O
impact Reason 2 O O
on Reason 2 O O
fertility Reason 2 O O
and Reason 2 O O
fetal Reason 2 O O
abnormalities, Reason 2 O O
the Reason 2 O O
report Reason 2 O O
includes Reason 2 O O
a Reason 2 O O
study Reason 2 O O
of Reason 2 O O
44 Reason 2 O O
rats Reason 2 O O
and Reason 2 O O
describes Reason 2 O O
two Reason 2 O O
main Reason 2 O O
metrics, Reason 2 O O
the Reason 2 O O
pre-implantation Reason 2 O O
loss Reason 2 O O
rate Reason 2 O O
and Reason 2 O O
the Reason 2 O O
number Reason 2 O O
of Reason 2 O O
abnormalities Reason 2 O O
per Reason 2 O O
fetus Reason 2 O O
(also Reason 2 O O
expressed Reason 2 O O
per Reason 2 O O
litter). Reason 2 O O
In Reason 2 O O
both Reason 2 O O
cases Reason 2 O O
the Reason 2 O O
metrics Reason 2 O O
were Reason 2 O O
significantly Reason 2 O O
higher Reason 2 O O
for Reason 2 O O
vaccinated Reason 2 O O
rats Reason 2 O O
than Reason 2 O O
for Reason 2 O O
unvaccinated Reason 2 O O
rats. Reason 2 O O
Roughly O O O O
speaking, O O O O
the O O O O
pre-implantation O O O O
loss O O O O
ratio O O O O
compares O O O O
the O O O O
estimated O O O O
number O O O O
of O O O O
fertilised O O O O
ova O O O O
and O O O O
the O O O O
ova O O O O
implanted O O O O
in O O O O
the O O O O
uterus. O O O O
The O O O O
table O O O O
below O O O O
is O O O O
taken O O O O
from O O O O
the O O O O
report O O O O
itself O O O O
and O O O O
clearly O O O O
shows O O O O
the O O O O
loss O O O O
rate O O O O
for O O O O
vaccinated O O O O
(BNT162b2) O O O O
is O O O O
more O O O O
than O O O O
double O O O O
the O O O O
unvaccinated O O O O
control O O O O
group. O O O O
In Reason 1 O O
a Reason 1 O O
case Reason 1 O O
control Reason 1 O O
study, Reason 1 O O
a Reason 1 O O
doubling Reason 1 O O
of Reason 1 O O
pregnancy Reason 1 O O
loss Reason 1 O O
in Reason 1 O O
the Reason 1 O O
intervention Reason 1 O O
group Reason 1 O O
would Reason 1 O O
represent Reason 1 O O
a Reason 1 O O
serious Reason 1 O O
safety Reason 1 O O
signal. Reason 1 O O
Rather Reason 1 O O
than Reason 1 O O
take Reason 1 O O
this Reason 1 O O
seriously, Reason 1 O O
the Reason 1 O O
authors Reason 1 O O
of Reason 1 O O
the Reason 1 O O
report Reason 1 O O
then Reason 1 O O
compared Reason 1 O O
the Reason 1 O O
outcomes Reason 1 O O
to Reason 1 O O
historical Reason 1 O O
data Reason 1 O O
on Reason 1 O O
other Reason 1 O O
rat Reason 1 O O
populations; Reason 1 O O
27 Reason 1 O O
studies Reason 1 O O
of Reason 1 O O
568 Reason 1 O O
rats, Reason 1 O O
and Reason 1 O O
ignored Reason 1 O O
the Reason 1 O O
outcome Reason 1 O O
because Reason 1 O O
other Reason 1 O O
populations Reason 1 O O
had Reason 1 O O
recorded Reason 1 O O
higher Reason 1 O O
overall Reason 1 O O
losses; Reason 1 O O
this Reason 1 O O
range Reason 1 O O
is Reason 1 O O
shown Reason 1 O O
in Reason 1 O O
the Reason 1 O O
right Reason 1 O O
hand Reason 1 O O
column Reason 1 O O
as Reason 1 O O
2.6 Reason 1 O O
percent Reason 1 O O
to Reason 1 O O
13.8 Reason 1 O O
percent. Reason 1 O O
This Reason 1 O O
analysis Reason 1 O O
is Reason 1 O O
alarming Reason 1 O O
as Reason 1 O O
remaining Reason 1 O O
below Reason 1 O O
the Reason 1 O O
highest Reason 1 O O
previously Reason 1 O O
recorded Reason 1 O O
pregnancy Reason 1 O O
loss Reason 1 O O
levels Reason 1 O O
in Reason 1 O O
populations Reason 1 O O
elsewhere Reason 1 O O
is Reason 1 O O
not Reason 1 O O
a Reason 1 O O
safe Reason 1 O O
outcome Reason 1 O O
when Reason 1 O O
the Reason 1 O O
intervention Reason 1 O O
is Reason 1 O O
also Reason 1 O O
associated Reason 1 O O
with Reason 1 O O
double Reason 1 O O
the Reason 1 O O
harm Reason 1 O O
of Reason 1 O O
the Reason 1 O O
control Reason 1 O O
group. Reason 1 O O
A O O O O
similar O O O O
pattern O O O O
is O O O O
observed O O O O
for O O O O
fetal O O O O
malformations O O O O
with O O O O
higher O O O O
abnormality O O O O
rate O O O O
in O O O O
each O O O O
of O O O O
the O O O O
12 O O O O
categories O O O O
studied. O O O O
Of O O O O
the O O O O
11 O O O O
categories O O O O
where O O O O
Pfizer O O O O
confirmed O O O O
the O O O O
data O O O O
is O O O O
correct, O O O O
there O O O O
are O O O O
only O O O O
2 O O O O
total O O O O
abnormalities O O O O
in O O O O
the O O O O
control O O O O
group, O O O O
versus O O O O
28 O O O O
with O O O O
the O O O O
mRNA O O O O
vaccine O O O O
(BNT162b2). O O O O
In Reason 1 O O
the Reason 1 O O
category Reason 1 O O
which Reason 1 O O
Pfizer Reason 1 O O
labeled Reason 1 O O
as Reason 1 O O
unreliable Reason 1 O O
(supernumerary Reason 1 O O
lumbar Reason 1 O O
ribs), Reason 1 O O
there Reason 1 O O
were Reason 1 O O
3 Reason 1 O O
abnormalities Reason 1 O O
in Reason 1 O O
the Reason 1 O O
control Reason 1 O O
group Reason 1 O O
and Reason 1 O O
12 Reason 1 O O
in Reason 1 O O
the Reason 1 O O
vaccinated Reason 1 O O
group. Reason 1 O O
As Reason 1 O O
with Reason 1 O O
the Reason 1 O O
increased Reason 1 O O
pregnancy Reason 1 O O
losses, Reason 1 O O
Pfizer Reason 1 O O
simply Reason 1 O O
ignored Reason 1 O O
the Reason 1 O O
trend Reason 1 O O
and Reason 1 O O
compared Reason 1 O O
the Reason 1 O O
results Reason 1 O O
with Reason 1 O O
historical Reason 1 O O
data Reason 1 O O
from Reason 1 O O
other Reason 1 O O
rat Reason 1 O O
populations. Reason 1 O O
This O O O O
is O O O O
very O O O O
significant O O O O
as O O O O
it O O O O
is O O O O
seen O O O O
across O O O O
every O O O O
malformation O O O O
category. O O O O
The O O O O
case O O O O
control O O O O
nature O O O O
of O O O O
the O O O O
study O O O O
design O O O O
is O O O O
again O O O O
ignored, O O O O
in O O O O
order O O O O
to O O O O
apparently O O O O
hide O O O O
the O O O O
negative O O O O
outcomes O O O O
demonstrated. O O O O
These O O O O
data O O O O
indicate O O O O
that O O O O
there O O O O
is O O O O
NO O O O O
basis O O O O
for O O O O
saying O O O O
the O O O O
vaccine O O O O
is O O O O
safe O O O O
in O O O O
pregnancy. O O O O
Concentration O O O O
of O O O O
LNPs O O O O
in O O O O
ovaries, O O O O
a O O O O
doubled O O O O
pregnancy O O O O
loss O O O O
rate, O O O O
and O O O O
raised O O O O
fetal O O O O
abnormality O O O O
rate O O O O
across O O O O
all O O O O
measured O O O O
categories O O O O
indicates O O O O
that O O O O
designating O O O O
a O O O O
safe-in-pregnancy O O O O
label O O O O
(B1 O O O O
category O O O O
in O O O O
Australia) O O O O
was O O O O
contrary O O O O
to O O O O
available O O O O
evidence. O O O O
The O O O O
data O O O O
implies O O O O
that O O O O
not O O O O
only O O O O
was O O O O
the O O O O
Government's O O O O
"safe O O O O
and O O O O
effective" O O O O
sloganeering O O O O
not O O O O
accurate, O O O O
it O O O O
was O O O O
totally O O O O
misleading O O O O
with O O O O
respect O O O O
to O O O O
the O O O O
safety O O O O
data O O O O
available. O O O O
Known Reason 3 O O
unknowns Reason 3 O O
and Reason 3 O O
missing Reason 3 O O
data: Reason 3 O O
Despite Reason 3 O O
the Reason 3 O O
negative Reason 3 O O
nature Reason 3 O O
of Reason 3 O O
these Reason 3 O O
outcomes, Reason 3 O O
the Reason 3 O O
classification Reason 3 O O
of Reason 3 O O
this Reason 3 O O
medicine Reason 3 O O
as Reason 3 O O
a Reason 3 O O
vaccine Reason 3 O O
appears Reason 3 O O
to Reason 3 O O
have Reason 3 O O
precluded Reason 3 O O
further Reason 3 O O
animal Reason 3 O O
trials. Reason 3 O O
Historically, Reason 3 O O
new Reason 3 O O
medicines, Reason 3 O O
especially Reason 3 O O
in Reason 3 O O
classes Reason 3 O O
never Reason 3 O O
used Reason 3 O O
in Reason 3 O O
humans Reason 3 O O
before, Reason 3 O O
would Reason 3 O O
require Reason 3 O O
a Reason 3 O O
very Reason 3 O O
rigorous Reason 3 O O
assessment. Reason 3 O O
Vaccines, Reason 3 O O
however, Reason 3 O O
have Reason 3 O O
a Reason 3 O O
lower Reason 3 O O
burden Reason 3 O O
of Reason 3 O O
proof Reason 3 O O
requirement Reason 3 O O
than Reason 3 O O
ordinary Reason 3 O O
medicines. Reason 3 O O
By O O O O
classifying O O O O
mRNA O O O O
injections O O O O
as O O O O
"vaccines," O O O O
this O O O O
ensured O O O O
regulatory O O O O
approval O O O O
with O O O O
significantly O O O O
less O O O O
stringent O O O O
safety O O O O
requirements, O O O O
as O O O O
the O O O O
TGA O O O O
itself O O O O
notes. O O O O
In O O O O
fact, O O O O
mRNA O O O O
gene O O O O
therapies O O O O
function O O O O
more O O O O
like O O O O
medicines O O O O
than O O O O
vaccines O O O O
in O O O O
that O O O O
they O O O O
modify O O O O
the O O O O
internal O O O O
functioning O O O O
of O O O O
cells, O O O O
rather O O O O
than O O O O
stimulating O O O O
an O O O O
immune O O O O
response O O O O
to O O O O
presence O O O O
of O O O O
an O O O O
antigen. O O O O
Labelling O O O O
these O O O O
gene O O O O
therapy O O O O
products O O O O
as O O O O
vaccines O O O O
means O O O O
that, O O O O
as O O O O
far O O O O
as O O O O
we O O O O
are O O O O
aware, O O O O
even O O O O
today O O O O
no O O O O
genotoxicity O O O O
or O O O O
carcinogenicity O O O O
studies O O O O
have O O O O
been O O O O
carried O O O O
out. O O O O
This O O O O
report, O O O O
which O O O O
was O O O O
only O O O O
released O O O O
after O O O O
a O O O O
FOI O O O O
request, O O O O
is O O O O
extremely O O O O
disturbing O O O O
as O O O O
it O O O O
shows O O O O
that O O O O
authorities O O O O
knew O O O O
of O O O O
major O O O O
risks O O O O
with O O O O
mRNA O O O O
Covid-19 O O O O
vaccination O O O O
while O O O O
simultaneously O O O O
assuring O O O O
populations O O O O
that O O O O
it O O O O
was O O O O
safe. O O O O
The O O O O
fact O O O O
that O O O O
mainstream O O O O
media O O O O
has O O O O
(as O O O O
far O O O O
as O O O O
we O O O O
are O O O O
aware) O O O O
completely O O O O
ignored O O O O
the O O O O
newly O O O O
released O O O O
data O O O O
should O O O O
reinforce O O O O
the O O O O
need O O O O
for O O O O
caution O O O O
when O O O O
listening O O O O
to O O O O
the O O O O
advice O O O O
of O O O O
public O O O O
health O O O O
messaging O O O O
regarding O O O O
Covid-19 O O O O
vaccination. O O O O
Firstly, O O O O
it Reason 2 O O
is Reason 2 O O
clear Reason 2 O O
that Reason 2 O O
regulators, Reason 2 O O
drug Reason 2 O O
companies Reason 2 O O
and Reason 2 O O
the Reason 2 O O
government Reason 2 O O
would Reason 2 O O
have Reason 2 O O
known Reason 2 O O
that Reason 2 O O
vaccine-induced Reason 2 O O
immunity Reason 2 O O
tails Reason 2 O O
off Reason 2 O O
very Reason 2 O O
rapidly Reason 2 O O
with Reason 2 O O
this Reason 2 O O
being Reason 2 O O
observed Reason 2 O O
in Reason 2 O O
real Reason 2 O O
world Reason 2 O O
data Reason 2 O O
with Reason 2 O O
efficacy Reason 2 O O
against Reason 2 O O
infection Reason 2 O O
falling Reason 2 O O
to Reason 2 O O
zero. Reason 2 O O
Accordingly, O O O O
the O O O O
single O O O O
point O O O O
in O O O O
time O O O O
figures O O O O
of O O O O
95 O O O O
percent O O O O
and O O O O
62 O O O O
percent O O O O
efficacy O O O O
against O O O O
cases O O O O
[quoted](https://www.nejm.org/doi/full/10.1056/NEJMoa2034577) O O O O
for O O O O
Pfizer O O O O
and O O O O
ChAdOx1 O O O O
( O O O O
[AstraZeneca](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext#tables)) O O O O
respectively O O O O
meant O O O O
almost O O O O
nothing O O O O
since O O O O
a O O O O
rapid O O O O
decline O O O O
was O O O O
to O O O O
be O O O O
expected. O O O O
Similarly, O O O O
the O O O O
concept O O O O
of O O O O
a O O O O
two-dose O O O O
"course" O O O O
was O O O O
inaccurate O O O O
as O O O O
endless O O O O
boosters O O O O
would O O O O
likely O O O O
have O O O O
been O O O O
required O O O O
given O O O O
the O O O O
rapid O O O O
decline O O O O
in O O O O
antibodies O O O O
and O O O O
T-cells O O O O
observed O O O O
in O O O O
the O O O O
monkeys. O O O O
Most O O O O
importantly, O O O O
the O O O O
data O O O O
does O O O O
not O O O O
in O O O O
any O O O O
way O O O O
support O O O O
the O O O O
"safe" O O O O
conclusion O O O O
with O O O O
respect O O O O
to O O O O
pregnancy; O O O O
a O O O O
conclusion O O O O
of O O O O
dangerous O O O O
would O O O O
be O O O O
more O O O O
accurate. O O O O
The O O O O
assurances O O O O
of O O O O
safety O O O O
were, O O O O
therefore, O O O O
completely O O O O
misleading O O O O
given O O O O
the O O O O
data O O O O
disclosures O O O O
in O O O O
the O O O O
recent O O O O
freedom O O O O
of O O O O
information O O O O
release. O O O O
Regulatory O O O O
authorities O O O O
knew O O O O
that O O O O
animal O O O O
studies O O O O
showed O O O O
major O O O O
red O O O O
flags O O O O
regarding O O O O
both O O O O
pregnancy O O O O
loss O O O O
and O O O O
fetal O O O O
abnormalities, O O O O
consistent O O O O
with O O O O
the O O O O
systemic O O O O
distribution O O O O
of O O O O
the O O O O
mRNA O O O O
they O O O O
had O O O O
been O O O O
hiding O O O O
from O O O O
the O O O O
public. O O O O
Even O O O O
in O O O O
March O O O O
2023, O O O O
it O O O O
is O O O O
impossible O O O O
to O O O O
give O O O O
these O O O O
assurances, O O O O
given O O O O
the O O O O
fact O O O O
that O O O O
important O O O O
studies O O O O
have O O O O
not, O O O O
to O O O O
the O O O O
best O O O O
of O O O O
our O O O O
knowledge, O O O O
been O O O O
done. O O O O
Pfizer O O O O
elected O O O O
not O O O O
to O O O O
follow O O O O
up O O O O
the O O O O
vast O O O O
majority O O O O
of O O O O
pregnancies O O O O
in O O O O
the O O O O
original O O O O
human O O O O
trials, O O O O
despite O O O O
high O O O O
miscarriage O O O O
rates O O O O
in O O O O
the O O O O
minority O O O O
they O O O O
did O O O O
follow. O O O O
Given O O O O
all O O O O
of O O O O
the O O O O
problems O O O O
with O O O O
efficacy O O O O
and O O O O
safety, O O O O
the O O O O
administration O O O O
of O O O O
these O O O O
products O O O O
to O O O O
women O O O O
of O O O O
childbearing O O O O
age, O O O O
and O O O O
administration O O O O
to O O O O
healthy O O O O
pregnant O O O O
women O O O O
is O O O O
high-risk O O O O
and O O O O
not O O O O
justified. O O O O
Read O O O O
